Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Trainer

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Clinical Endocrinology|April 24, 2004
Growth hormone assay standardization: a biased view?G E Wieringa, J H Barth, P J Trainer
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 19, 2006
Effect of growth hormone in an experimental model of protein hypercatabolism induced by glucocorticoidsA Cantón, P J Trainer, E Martinez-Cáceres, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|March 1, 1993
Effect of recombinant insulin-like growth factor I on anterior pituitary function in healthy volunteersP J Trainer, J Holly, S Medbak, et al.
Clinical Endocrinology|April 28, 2011
Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approachesI Perogamvros, M Kayahara, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2010
Salivary cortisone is a potential biomarker for serum free cortisolI Perogamvros, B G Keevil, D W Ray, et al.
Trends in Endocrinology and Metabolism: TEM|October 12, 2001
Clinical use of a growth hormone receptor antagonist in the treatment of acromegalyW M Drake, C Parkinson, G M Besser, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normalC Parkinson, M Kassem, L Heickendorff, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2009
A subnormal peak cortisol response to stimulation testing does not predict a subnormal cortisol production rateA N Paisley, S V Rowles, D Brandon, et al.
BMJ (Clinical Research Ed.)|July 1, 1989
Immunoscintigraphy with monoclonal antibodiesK C McHardy, R Harvey, P J Trainer, et al.
Endocrine Reviews|October 10, 2002
Growth hormone receptor antagonists: discovery, development, and use in patients with acromegalyJ J Kopchick, C Parkinson, E C Stevens, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Clinical Endocrinology|April 24, 2004
Growth hormone assay standardization: a biased view?G E Wieringa, J H Barth, P J Trainer
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 19, 2006
Effect of growth hormone in an experimental model of protein hypercatabolism induced by glucocorticoidsA Cantón, P J Trainer, E Martinez-Cáceres, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|March 1, 1993
Effect of recombinant insulin-like growth factor I on anterior pituitary function in healthy volunteersP J Trainer, J Holly, S Medbak, et al.
Clinical Endocrinology|April 28, 2011
Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approachesI Perogamvros, M Kayahara, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2010
Salivary cortisone is a potential biomarker for serum free cortisolI Perogamvros, B G Keevil, D W Ray, et al.
Trends in Endocrinology and Metabolism: TEM|October 12, 2001
Clinical use of a growth hormone receptor antagonist in the treatment of acromegalyW M Drake, C Parkinson, G M Besser, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normalC Parkinson, M Kassem, L Heickendorff, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2009
A subnormal peak cortisol response to stimulation testing does not predict a subnormal cortisol production rateA N Paisley, S V Rowles, D Brandon, et al.
BMJ (Clinical Research Ed.)|July 1, 1989
Immunoscintigraphy with monoclonal antibodiesK C McHardy, R Harvey, P J Trainer, et al.
Endocrine Reviews|October 10, 2002
Growth hormone receptor antagonists: discovery, development, and use in patients with acromegalyJ J Kopchick, C Parkinson, E C Stevens, et al.
Pageof 11